Pancreatic adenocarcinoma-associated polymyositis treated with corticosteroids along with cancer specific treatment: Case report

BMC Gastroenterology

Volumn 11, Issue , 2011, Pages

  Syrios, John ^a   Kechagias, Georgios ^a   Xynos, Ioannis D ^a   Gamaletsou, Maria N ^a   Papageorgiou, Aristea ^a   Agrogiannis, George ^a   Tsavaris, Nicolas ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ERLOTINIB; GEMCITABINE; METHYLPREDNISOLONE; ANTINEOPLASTIC ANTIMETABOLITE; DEOXYCYTIDINE; DRUG DERIVATIVE; GLUCOCORTICOID; QUINAZOLINE DERIVATIVE;

ADULT; ARTICLE; CANCER RELAPSE; CANCER STAGING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG RESPONSE; HUMAN; HUMAN TISSUE; MALE; MULTIPLE CYCLE TREATMENT; MUSCLE BIOPSY; MUSCLE WEAKNESS; PANCREAS ADENOCARCINOMA; PERIPHERAL EDEMA; POLYMYOSITIS; ADENOCARCINOMA; CD8+ T LYMPHOCYTE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; MIDDLE AGED; PANCREAS TUMOR; PATHOLOGY; SCINTISCANNING;

ADENOCARCINOMA; ANTIMETABOLITES, ANTINEOPLASTIC; CD8-POSITIVE T-LYMPHOCYTES; DEOXYCYTIDINE; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; POLYMYOSITIS; QUINAZOLINES;

EID: 79953710035     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-11-33     Document Type: Article

References (15)

1. Lim JE, Chien MW, Earle CC. Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients. Ann Surg 2003, 237:74-85. 10.1097/00000658-200301000-00011, 1513971, 12496533.
2. Sigurgeirsson B, Lindelof B, Edhag O, Allander E. Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study. N Engl J Med 1992, 326:363-367. 10.1056/NEJM199202063260602, 1729618.
3. Carpenter JR, Bunch TW, Engel AG, O'Brien PC. Survival in polymyositis: corticosteroids and risk factors. J Rheumatol 1977, 4:207-214.
4. Maugars YM, Berthelot JM, Abbas AA, Mussini JM, Nguyen JM, Prost AM. Long-term prognosis of 69 patients with dermatomyositis or polymyositis. Clin Exp Rheumatol 1996, 14:263-274.
5. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975, 292:344-347. 10.1056/NEJM197502132920706, 1090839.
6. Hill CL, Zhang Y, Sigurgeirsson B, Pukkala E, Mellemkjaer L, Airio A, Evans SR, Felson DT. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet 2001, 357:96-100. 10.1016/S0140-6736(00)03540-6, 11197446.
7. Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet 2003, 362:971-982. 10.1016/S0140-6736(03)14368-1, 14511932.
8. Bohan A, Peter JB, Bowman RL, Pearson CM. Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore) 1977, 56:255-286.
9. Targoff IN. Myositis specific autoantibodies. Curr Rheumatol Rep 2006, 8:196-203. 10.1007/s11926-996-0025-3, 16901077.
10. Targoff IN, Mamyrova G, Trieu EP, Perurena O, Koneru B, O'Hanlon TP, Miller FW, Rider LG. A novel autoantibody to a 155-kd protein is associated with dermatomyositis. Arthritis Rheum 2006, 54:3682-3689. 10.1002/art.22164, 17075819.
11. Emslie-Smith AM, Arahata K, Engel AG. Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies. Hum Pathol 1989, 20:224-231. 10.1016/0046-8177(89)90128-7, 2470663.
12. Ardavanis AS, Ioannidis GN, Rigatos GA. Acute myopathy in a patient with lung adenocarcinoma treated with gemcitabine and docetaxel. Anticancer Res 2005, 25:523-525.
13. Joffe MM, Love LA, Leff RL, Fraser DD, Targoff IN, Hicks JE, Plotz PH, Miller FW. Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficacy. Am J Med 1993, 94:379-387. 10.1016/0002-9343(93)90148-I, 8386437.
14. Okada T, Noji S, Goto Y, Iwata T, Fujita T, Matsuzaki Y, Kuwana M, Hirakata M, Horii A, Matsuno S, Sunamura M, Kawakami Y. Immune responses to DNA mismatch repair enzymes hMSH2 and hPMS1 in patients with pancreatic cancer, dermatomyositis and polymyositis. Int J Cancer 2005, 116:925-933. 10.1002/ijc.21118, 15856462.
15. Egberts JH, Schniewind B, Patzold M, Kettler B, Tepel J, Kalthoff H, Trauzold A. Dexamethasone reduces tumor recurrence and metastasis after pancreatic tumor resection in SCID mice. Cancer Biol Ther 2008, 7:1044-1050.